Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19-Reference-Cited by-同舟云学术

Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19

Published:2020-05 Issue:5 Volume:36 Page:784.e1-784.e2
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Bombardini Tonino,Picano Eugenio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference4 articles.

1. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) China;China CDC Weekly,2020

2. ACE and ACE2: a tale of two enzymes;Zisman;Eur Heart J,2005

3. Angiotensin-converting enzyme 2 protects from severe acute lung failure;Imai;Nature,2005

4. ESC Council on Hypertension on behalf of the Nucleus Members. Position Statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers;De Simone;March,2020

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory Effects of Vitamin D and Zinc on Viral Infection;Biological Trace Element Research;2024-03-07

2. Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial;BMC Complementary Medicine and Therapies;2024-02-21

3. An Insight into COVID-19 and Traditional Herbs: Bangladesh Perspective;Medicinal Chemistry;2023-05

4. Biphenyl furanocoumarin compounds inhibit SARS-CoV-2 spike pseudovirus infection by binding ACE2;New Journal of Chemistry;2023

5. Evaluation of lactate dehydrogenase (LDH) in predicting the severity of lung involvement and pneumomediastinum in hospitalized COVID-19;Medicina Clínica Práctica;2022-10